8 studies found for:    CYBB
Show Display Options
Rank Status Study
1 Completed Sex-specific Association With Kidney Disease
Condition: Diabetic Nephropathy
Intervention:
2 Terminated Gene Therapy for Chronic Granulomatous Disease
Condition: Chronic Granulomatous Disease
Intervention: Drug: Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells
3 Withdrawn Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD)
Condition: Granulomatous Disease, Chronic, X-linked, Variant
Intervention: Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion
4 Completed Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children
Condition: Chronic Granulomatous Disease
Intervention: Genetic: retroviral SF71-gp91phox transduced CD34+ cells
5 Unknown  Gene Therapy for Chronic Granulomatous Disease
Condition: Granulomatous Disease, Chronic
Intervention: Drug: retroviral SF71-gp91phox transduced CD34+ cells
6 Recruiting Gene Therapy for X-CGD
Condition: X-linked Chronic Granulomatous Disease
Intervention: Genetic: ex-vivo gene-therapy
7 Recruiting Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
Conditions: Type 2 Diabetes Mellitus;   Hypercholesterolemia
Interventions: Drug: Atorvastatin;   Drug: Placebo
8 Recruiting Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)
Condition: X-Linked Chronic Granulomatous Disease
Intervention: Genetic: X vivo gene therapy

Indicates status has not been verified in more than two years